Continuous longitudinal infusion of rhIGF-1/rhIGFBP-3 in extremely preterm infants: Evaluation of feasibility in a phase II study. [electronic resource]
Producer: 20180627Description: 44-51 p. digitalISSN:- 1532-2238
- Blood Glucose -- analysis
- Feasibility Studies
- Female
- Gestational Age
- Humans
- Infant
- Infant, Extremely Premature -- physiology
- Infant, Newborn
- Insulin-Like Growth Factor Binding Protein 3 -- administration & dosage
- Insulin-Like Growth Factor I -- administration & dosage
- Longitudinal Studies
- Male
- Recombinant Proteins -- administration & dosage
- Retinopathy of Prematurity -- prevention & control
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.